The Schistosoma mansoni Hepatic Egg Granuloma Provides a Favorable Microenvironment for Sustained Growth of Leishmania donovani-Reference-Cited by-同舟云学术

The Schistosoma mansoni Hepatic Egg Granuloma Provides a Favorable Microenvironment for Sustained Growth of Leishmania donovani

Published:2006-09 Issue:3 Volume:169 Page:943-953
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Hassan Mohammed F.,Zhang Yaobi,Engwerda Christian R.,Kaye Paul M.,Sharp Hannah,Bickle Quentin D.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference77 articles.

1. Leishmaniais in the Sudan Republic. 30. Final epidemiological report;Hoogstraal;Am J Trop Med Hyg,1969

2. The Blue Nile Health Project: a comprehensive approach to the prevention and control of water-associated diseases in irrigated schemes of the Sudan;el Gaddal;J Trop Med Hyg,1985

3. Kala-azar in displaced people from southern Sudan: epidemiological, clinical and therapeutic findings;Zijlstra;Trans R Soc Trop Med Hyg,1991

4. Th2 response polarization during infection with the helminth parasite Schistosoma mansoni;Pearce;Immunol Rev,2004

5. Tissue granuloma structure-function in experimental visceral leishmaniasis;Murray;Int J Exp Pathol,2001

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond schistosomiasis: unraveling co-infections and altered immunity;Clinical Microbiology Reviews;2024-03-14

2. Altered purinergic P2X7 and A2B receptors signaling limits macrophage-mediated host defense in schistosomiasis;Biomedical Journal;2024-03

3. Wuchereria bancrofti infection is associated with progression to clinical visceral leishmaniasis in VL- endemic areas in Muzaffarpur, Bihar, India;PLOS Neglected Tropical Diseases;2023-10-30

4. Schistosoma and Leishmania: An Untold Story of Coinfection;Tropical Medicine and Infectious Disease;2023-07-27

5. Unwelcome prevalence of leishmaniasis with several other infectious diseases;International Immunopharmacology;2022-09